David is President at Tress Capital, an established investment management firm in the cannabis sector, founded in 2013. Tress originates, guides, and manages investment for HNW, SFO, and institutional clients in both fund and bespoke SMA vehicles. Tress works closely with its companies and sector as an active value-add investor. Its portfolio includes industry leaders such as SC Labs, Headset, Baker Technologies, Cannabis Now, Infusion Biosciences, Grownetics and North Bud Farms. A two time cancer survivor, David was introduced to the vast benefits of medical cannabis while undergoing cancer treatments in 2001 and again in 2003. David has since dedicated himself to furthering research, awareness, and business opportunities in the expanding cannabis industry.